Eclusive PCCA Bases Quick-Reference Poster | © PCCA 2019See PCCA Document #99650 for a short booklet highlighting PCCA’s most popular bases.
PCCA Exclusive Base Dosage Form(s) Ideal in Formulations For Common APIs Example Formulas
Atrevis™ HydrogelPCCA #30-4986
• Superior testosterone delivery backed up by independent testing
• Alcohol-free for better stability and less irritation
• Quick absorption, smooth texture, and no greasy residue
Topical gel Testosterone replacement Testosterone
• PCCA Formula #12674 Testosterone 0.5% to 20% (Bracketed)
• PCCA Formula #12676 Testosterone 5%/Anastrozole 0.05%/HCG 500 U/Gm
• PCCA Formula #12681 Testosterone 5%/Finasteride 0.1%
Clarifying Base™
PCCA #30-4845
• Topical base that moisturizes and supports healthy skin
• May improve the appearance of red, blotchy skin
• Easily accommodates antimicrobials, benzoyl peroxide, tretinoin, alpha and beta hydroxy acids, and more
Topical cream
• Acne/problem skin
• Rosacea
• Aging skin prone to acne
• Benzoyl peroxide
• Salicylic acid
• Tretinoin
• Erythromycin
• PCCA Formula #11800 Clindamycin 1%/Benzoyl Peroxide 5%/Superoxide Dismutase 0.5%/Vitamin D3 0.5%
• PCCA Formula #11710 Niacinamide 5%/Glycosaminoglycans 5%/Dimethyl Sulfone 2%/Biotin 0.2%
• PCCA Formula #11713 Sodium Hyaluronate 0.05%/Collagen/Aloe Vera/Glycolic Acid/Vitamin E
Lipoderm®
PCCA #30-3338
• Validated vehicle for deep-penetrating topical formulations and transdermal formulations
• Patented transdermal technology backed by numerous peer-reviewed studies
• Over 15 formulas with extended beyond-use datesTransdermal cream
• Acute or chronic pain
• Anxiety
• Nausea
• Veterinary medicine
• Analgesics and anesthetics
• Anxiolytics
• Antiemetics
• PCCA Formula #10835 Ketamine HCl 5%/Gabapentin 10%/Clonidine HCl 0.2%/ Baclofen 2%
• PCCA Formula #12375 Promethazine HCl 12.5 mg/Gm to 25 mg/Gm Topical (Bracketed)
• PCCA Formula #12373 Methimazole 2.5 mg/0.1 Gm to 10 mg/0.1 Gm (Bracketed)
Lipoderm ActiveMax®
PCCA #30-4482
• Developed for APIs in salt form at high concentrations
• Uses the same patented transdermal system as Lipoderm
• Eight formulas with extended beyond-use dates
APIs that are in a salt form (e.g., Cl, Na)
• PCCA Formula #10287 Diclofenac Sodium 5%/Gabapentin 5%/Amitriptyline HCl 2%
• PCCA Formula #11090 Flurbiprofen 10%/Baclofen 2%/Cyclobenzaprine HCl 2%/Tetracaine 2%
• PCCA Formula #10673 Clomiphene Citrate 5%
LoxaSperse®
PCCA #30-4701
• Powder base that provides topical delivery to the nasal and sinus cavities when reconstituted
• Reduces particle size and increases dispersibility and solubility of APIs
• Easy to store and carry with prolonged beyond-use date in powder/capsule preparation
• Commonly compounded with PCCA XyliFos® (PCCA #30-4894)
Nasal nebulization and irrigation Chronic sinus conditions
• Antifungals
• Antibiotics
• Corticosteroids
• PCCA Formula #12850 Mupirocin 5 mg/Budesonide 0.6 mg Capsules Size #1
• PCCA Formula #12855 Tobramycin 20 mg/Budesonide 0.6 mg Capsules Size #1
• PCCA Formula #12857 Clindamycin 30 mg/Budesonide 0.6 mg Capsules Size #1
LoxOral®PCCA #30-4774
• Powder base that makes capsules easier to prepare and saves time
• Reduces static, making micronized powders easier to work with
• Provides even distribution and improved dissolution of APIs
Oral capsules
• Oral hormone replacement therapy (HRT)
• General systemic medication
• Veterinary medicine
• Progesterone
• Estriol
• Estradiol
• PCCA Formula #11296 Estriol/Estradiol [80%/20%] 2 mg/Progesterone 100 mg/Testosterone 0.5 mg/DHEA 25 mg Slow Release Capsules Size #0
• PCCA Formula #10797 Progesterone 100 mg Slow Release Capsules Size #1
• PCCA Formula #10805 Naltrexone HCl 0.5 mg Capsules Size #1
MucoLox™
PCCA #30-4782
• Unique liquid-gel base that adheres to mucosa up to 24 times longer than other products
• Increases contact time between APIs and mucosa
• Can be diluted with water to adjust viscosity
• Commonly compounded with VersaBase® Gel (PCCA #30-3656) to create vaginal gels
• Oral, vaginal or rectal gel
• Oral mouthwash or spray
• Esophageal/gut suspension
• Vaginal HRT
• Oral mucositis
• Proctitis
• Hormones
• Anesthetics
• Corticosteroids
• PCCA Formula #11115 Estriol 0.05% Vaginal Gel
• PCCA Formula #12066 Stanford Modified Oral Rinse (Lab Study)
• PCCA Formula # 12228 Budesonide 1 mg/10 mL to 2 mg/10 mL Oral Suspension
(Bracketed)
PracaSil®-PlusPCCA #30-4655
• Anhydrous topical silicone base that provides superior moisturization and protection
• Contains pracaxi oil that is rich in skin-friendly fatty acids and lipids
• Promotes a soothing and nurturing environment
Topical gel
• All scars, including new, old, keloid, hypertrophic and surgical
• Burns and diabetic wounds
• Stretch marks
• Corticosteroids and antioxidants
• Anesthetics and NSAIDs
• Antibiotics and antifungals
• PCCA Formula #10826 Fluocinolone Acetonide 0.01%/Hydroquinone 4%/Tretinoin 0.05%
• PCCA Formula #10419 Tretinoin 0.1%
• PCCA Formula #10234 Tamoxifen Citrate 0.1%/Tranilast 1%/Caffeine Citrated 0.1%/Lipoic Acid 0.5%
SuspendIt®
PCCA #30-4825
• Oral-suspension base that thins when shaken and thickens when standing
• Minimizes sedimentation and allows for rapid redispersion of APIs with agitation
• All-natural sweetness derived from monk fruit
Oral suspension
• Pediatric compounding
• Hospice and oncology
• Veterinary medicine
• Proton-pump inhibitors
• Corticosteroids
• Anticonvulsants
• PCCA Formula #11262 Omeprazole 2 mg/mL to 10 mg/mL (Bracketed)
• PCCA Formula #12539 Phenobarbital 1 mg/mL to 50 mg/mL (Bracketed)
• PCCA Formula #5374 Cisapride 10 mg/mL (Vet)
VersaBase® CreamPCCA #30-3641
• Elegant yet durable topical cream that is stable over a broad pH range (3.5-12)
• Noncomedogenic, hypoallergenic, nonirritating and odor-free
• Formulated without oil, petrolatum, parabens and propylene glycol
• Topical cream
• Vaginal cream
• Hormone Replacement Therapy (HRT)
• General topical compounding
• Estriol
• Estradiol
• Progesterone
• PCCA Formula #12116 Estriol/Estradiol [50%/50%] 0.25 mg/0.5 Gm to 1 mg/0.5 Gm Topical Cream (Bracketed)
• PCCA Formula #12114 Progesterone 10 mg/Gm to 100 mg/Gm Topical Cream (Bracketed)
• PCCA Formula #12227 Amitriptyline HCl 0.25% to 5% Vaginal Cream (Bracketed)
XemaTop™
PCCA #30-4891
• Topical base containing a skin-friendly blend of boswellic acid, avenanthramides from oats, phosphatidylglycerol and film formers
• Moisturizes while nourishing the skin’s structural integrity
• May improve the appearance of red, irritated, flaky skin
Topical cream
• Eczema
• Psoriasis
• Xerosis (dry skin)
• Corticosteroids
• Vitamins B, D and E, and derivatives
• Zinc pyrithione
• PCCA Formula #12371 Cyanocobalamin 0.07% to 1% (Bracketed)
• PCCA Formula #12374 Pentoxifylline 5% to 15% (Bracketed)
• PCCA Formula #11788 Zinc Pyrithione 0.2%/Clobetasol Propionate 0.05%/Cyanocobalamin 0.07%
= FormulaPlus™ BUD StudyExclusive PCCA Bases Quick-Reference Poster | For studies on these bases, visit pccarx.com/science.